Literature DB >> 4846488

Quantitative studies on tumor enhancement in mice. I. Enhancement of sarcoma I induced by IgM, IgG1, and IgG2.

P Rubinstein, F Decary, E W Streun.   

Abstract

The concentration of specific alloantibody in purified mouse immunoglobulin preparations was determined. When passively transferred in adequate doses, IgM, IgG1, and IgG2 antibodies all induced tumor enhancement in allogeneic hosts. IgM and IgG2 antibodies in high concentration led to inhibition of tumor growth. IgM and either IgG1 or IgG2 had additive effects on tumor enhancement. IgG1, but not IgG2, suppressed the inhibitory effect of IgM in high concentration.

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4846488      PMCID： PMC2139585          DOI： 10.1084/jem.140.2.591

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  11 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Immunological tumor enhancement and in vitro cytotoxicity. Further evidence for the involvement of 7S 2a-immunoglobulin.

Authors:  J C Eustace; G L Irvin
Journal:  Transplantation       Date:  1973-09       Impact factor: 4.939

3.  Biological properties of transplantation immune sera. 3. Relationship between transplantation (facilitation or inhibition) and serological (anaphylaxis or cytolysis) activities.

Authors:  R G Kinsky; G A Voisin; H T Duc
Journal:  Transplantation       Date:  1972-05       Impact factor: 4.939

Review 4.  Immunological enhancement: a study of blocking antibodies.

Authors:  J D Feldman
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

5.  Single dilution radio-immune assay for the determination of anti-Rh-o (D) content of Rh-o (D) immune globulin.

Authors:  E B Paul; V M Esposito
Journal:  Biochem Biophys Res Commun       Date:  1970-09-30       Impact factor: 3.575

Review 6.  Regulatory effect of antibody on the immune response.

Authors:  J W Uhr; G Möller
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

7.  Immunochemical and biologic characterization of alloantibody active in immunologic enhancement.

Authors:  T C Fuller; H J Winn
Journal:  Transplant Proc       Date:  1973-03       Impact factor: 1.066

8.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

Review 9.  Immunological facilitation, a broadening of the concept of the enhancement phenomenon.

Authors:  G A Voisin
Journal:  Prog Allergy       Date:  1971

10.  Letter: H-2 typing with the polyvinylpyrrolidone (PVP) method.

Authors:  P Rubinstein; N Kaliss
Journal:  Transplantation       Date:  1974-01-01       Impact factor: 4.939
View more
  3 in total

1.  Immunogenic cells in the regional lymph nodes after painting with the contact sensitizers picryl chloride and oxazolone: evidence for the presence of IgM antibody on their surface.

Authors:  G L Asherson; V Colizzi; M C Watkins
Journal:  Immunology       Date:  1983-03       Impact factor: 7.397

2.  The role of nonclassical Fc receptor-associated, Ag-B antigens (Ia) in rat allograft enhancement.

Authors:  J P Soulillou; C B Carpenter; A J d'Apice; T B Strom
Journal:  J Exp Med       Date:  1976-02-01       Impact factor: 14.307

3.  Antibody-mediated suppression of grafted lymphoma. IV. Influence of time of tumor residency in vivo and tumor size upon the effectiveness of suppression by syngeneic antibody.

Authors:  H S Shin; J S Economou; G R Pasternack; R J Johnson; M L Hayden
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.